.jpg)
Testosterone drugs have been in the news lately. Testosterone replacement drugs have become popular in the United States. The 2013 sales of one testosterone drug were $1.4 billion in the United States. Currently, a multi-state class action lawsuit has been initiated against a prominent testosterone restorative drug. Recently, a federal judge declined to drop an international company that makes the testosterone drug, and its licensee, in the United States from the lawsuit. The lawsuit alleges that the testosterone drug is ineffective and harmful. Some jurisdictional questions, however, remain open.
The class action lawsuit for greater than 2,000 complainants was consolidated in 2014. The complainants are from across the United States and the lawsuit is against a number of companies for injuries the complainants allege they have suffered from using the testosterone replacement drugs made by the companies that are a part of the lawsuit. One of the brand name drugs being targeted has been approved by the Food and Drug Administration.
As a recent part of the ongoing drug lawsuit, some claims were dropped as to the international company, however, the remaining claims are for design defect and negligence, as well as additional claims for damages. The claimants allege that the drug is useless and causes blood clots and other types of cardiovascular harm. A number of issues currently remain unresolved in the ongoing lawsuit. Some of the outstanding issues, as the lawsuit moves forward, include whether a safer alternative design is available and if and how the drug lacks any medical benefit.
While pharmaceuticals provide help each day for many individuals, they can also provide harm. Because drug lawsuits can be a complex area of the law, it is important that individuals negatively impacted by a bad drug, and companies engaged in the costly drug production process, are familiar with legal rights and remedies available to them when concerns arise.
